Streetbeat News

Stock Prices

ETCUSD

Ethereum Classic (ETC) experienced a 3.51% price decrease over the last 24 hours, marking a continuation of its 8.0% decline over the past week. The current price stands at $25.41. Despite the drop, trading volume has risen by 6.0% and the circulating supply increased by 0.69% to over 147.05 million, representing approximately 69.79% of its maximum supply. Ethereum Classic's market cap ranking is now #31, with a valuation of $3.74 billion.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 7:00 pm

QBTS

D-Wave Quantum Inc (QBTS) receives positive analyst coverage with a focus on its fast anneal technology, which accelerates quantum processing speeds. Needham, Benchmark, and Piper Sandler analysts reiterate Buy or Overweight ratings with price targets ranging from $2.50 to $4. Despite reporting lower-than-expected revenues for the quarter at $2.5 million, the company shows strong year-over-year bookings growth and technological advancements, including the development of a 4,800+ qubit processor for its upcoming Advantage2 system.

Portfolio Pulse from Anusuya Lahiri

May 14, 2024 | 6:54 pm

HOOD

A significant options trade was executed for Robinhood Markets (HOOD), involving a sweep of 820 calls for June 21 at a strike price of $19, priced at $1.08 each. This trade occurred near the ask price, with the stock reference price at $17.985. The open interest for these options was 5,385 prior to the trade.

Portfolio Pulse from Charles Gross

May 14, 2024 | 6:49 pm

VRSK

Verisk Analytics (NYSE:VRSK) has seen a decrease in short interest, now at 1.64% of float, lower than its peer group average of 3.08%. This reduction suggests a more bullish market sentiment towards VRSK, contrasting with the general perception that increasing short interest indicates bearish sentiment. The current short interest represents 2.07 million shares, with a coverage time of 2.43 days based on trading volume.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 6:45 pm

RTX

RTX's short interest has increased by 6.51%, with 36.95 million shares sold short, representing 2.78% of its float. This indicates a bearish market sentiment towards RTX, although it has more short interest compared to its peers' average of 2.35%. The rise in short interest does not necessarily predict a price drop but suggests increased bearish sentiment.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 6:45 pm

AA

Alcoa Corporation (NYSE:AA) has seen a 7.28% increase in its short percent of float since the last report, reaching 11.05% of all regular shares available for trading. With 15.41 million shares sold short, it would take about 2.3 days for traders to cover their short positions. This rise in short interest indicates a more bearish market sentiment towards Alcoa, although it doesn't necessarily predict a near-term price fall. Compared to its peers, Alcoa has a higher short interest, suggesting more bearish sentiment among investors towards it than its industry counterparts.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 6:45 pm

MDT

PODD

Blue Orca Capital released a report shorting Insulet Corporation (PODD) and favoring EOFlow after a court ruling ended Insulet's injunction against EOFlow, threatening Insulet's monopoly in the automated insulin delivery systems market. The ruling allows competition and could significantly impact Insulet's market position and share price, which is anticipated to drop over 15%. Conversely, EOFlow's stock value is expected to see a resurgence. Insulet had previously reported strong Q1 earnings, but the court's decision introduces uncertainty into its future performance.

Portfolio Pulse from Vandana Singh

May 14, 2024 | 6:44 pm

INO

Stephens initiated coverage on INOVIO Pharmaceuticals Inc (NASDAQ:INO) with an Overweight rating and a price target of $20, highlighting the company's diversified clinical pipeline and the potential of its lead program INO-3107 for Accelerated Approval by the FDA. INO-3107, aimed at treating recurrent respiratory papillomatosis (RRP), could become the first non-surgical treatment for RRP. The FDA marketing application submission for INO-3107 is expected in the second half of 2024. The company's DNA Medicines pipeline also includes early-stage programs for various diseases. The analyst believes the leadership's efficiencies will de-risk the platform technology.

Portfolio Pulse from Vandana Singh

May 14, 2024 | 6:37 pm

EW

Edwards Lifesciences Corporation (NYSE:EW) faces an EU antitrust complaint from Indian competitor Meril, alleging anti-competitive behavior over heart valve patents. This could increase scrutiny from EU regulators, amid broader efforts to ensure competition and affordability in healthcare. Edwards, known for its TAVR device, denies the accusations, citing past legal victories over Meril's Myval system. The European Commission is investigating Edwards' business practices.

Portfolio Pulse from Vandana Singh

May 14, 2024 | 6:33 pm

ALAB

QCOM

The AI industry is poised for a wave of mergers and acquisitions (M&A) as companies running low on funds look for exits, with Astera Labs' recent IPO being an exception. Hugging Face's CEO highlighted the risky bets and financial struggles within the sector. The lack of widespread AI application and high operating costs are pushing smaller firms towards consolidation with larger entities. Qualcomm is participating in an upcoming AI summit, indicating interest in the evolving AI landscape. OpenAI's release of GPT-4o suggests advancements in AI technology, while the overall M&A activity in AI has already exceeded last year's total, with $35 billion spent across 104 deals.

Portfolio Pulse from Natan Ponieman

May 14, 2024 | 6:31 pm